What does BELRO MEDICAL do?

BELRO MEDICAL is registered with the CBE as active in: Activiteiten van holdings. Public Limited, started on 16 August 1994, 1 establishment.

What is the address of BELRO MEDICAL?

The registered office of BELRO MEDICAL is located at Drève Richelle 161 box 28, 1410 Waterloo.

Is BELRO MEDICAL still active?

Yes. According to the CBE (31 October 2026) BELRO MEDICAL is active, legal situation “Normale toestand”, started on 16 August 1994.

Is BELRO MEDICAL registered on Peppol?

Yes, BELRO MEDICAL is registered on the Peppol network with ID 0208:0453278228.

What is the enterprise number of BELRO MEDICAL?

The enterprise number of BELRO MEDICAL is BE0453278228.

When was BELRO MEDICAL founded?

BELRO MEDICAL was founded on 16 August 1994.

Who are the directors of BELRO MEDICAL?

According to the 2025 annual accounts, the directors of BELRO MEDICAL are: Alexandra. VEITHEN., Noleen Shiela MC CLOSKEY, Alexandra VEITHEN, PHILIPPE MARCHAND.

Is BELRO MEDICAL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 16 August 1994; 5 annual accounts filed, latest fiscal year 2025; 4 directors known from the annual account.

How much profit did BELRO MEDICAL make in 2025?

BELRO MEDICAL recorded a loss after taxes of € 66,163 in financial year 2025.

What is the revenue of BELRO MEDICAL?

As a small company, BELRO MEDICAL is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 3,403,536.

How much does an employee at BELRO MEDICAL earn?

The average wage cost per full-time employee at BELRO MEDICAL was € 343,000 in 2025: staff costs of € 3.7 million for 10.8 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does BELRO MEDICAL have?

According to the 2025 annual accounts, BELRO MEDICAL has 10.8 full-time equivalents (FTE).

BELRO MEDICAL (Public Limited) - Waterloo - BE0453278228

Dossier BELRO MEDICAL, printed on 31 October 2026 from databakkes.be/en/0453278228/belro-medical. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.
Busy address KBO

10 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2025

BELRO MEDICAL from Waterloo, company number BE0453278228, closed financial year 2025 with a result of € -66,163 after tax. For that financial year BELRO MEDICAL recorded a gross margin of € 3.4 million and equity of € 15.9 million. Compared with financial year 2024, the result moved from € -1.4 million to € -66,163. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 8, 2026.

What it is worth Healthy

€ 15.9 million

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -66,163

▲ 95 % less loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 1.4 million

▲ 29% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 952,351.

People and assets in 2025

Full-time equivalents

10.8

▼ 1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 3.7 million

▲ 13% vs 2024

€ 343,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 38,147

▲ 16% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 2.2 million

▲ 27% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 676,337

▲ 22% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 2,408,246 Gross margin 2022: € 2,408,246 First fiscal year in the series	€ 2,809,224 Gross margin 2023: € 2,809,224 ▲ 17% vs 2022 (€ 2,408,246) Favourable step	€ 5,585,116 Gross margin 2024: € 5,585,116 ▲ 99% vs 2023 (€ 2,809,224) Favourable step	€ 3,403,536 Gross margin 2025: € 3,403,536 ▼ 39% vs 2024 (€ 5,585,116) Unfavourable step	▼ 39%
Profit after taxes	€ 77,174 Profit after taxes 2022: € 77,174 First fiscal year in the series	€ 77,036 Profit after taxes 2023: € 77,036 Unchanged (€ 77,174) Unfavourable step	€ -1,404,941 Profit after taxes 2024: € -1,404,941 ▼ € 1.5 million vs 2023 (€ 77,036) Unfavourable step	€ -66,163 Profit after taxes 2025: € -66,163 ▲ € 1.3 million vs 2024 (€ -1,404,941) Favourable step	▲ € 1.3 million
Equity	€ 3,263,626 Equity 2022: € 3,263,626 First fiscal year in the series	€ 3,340,662 Equity 2023: € 3,340,662 ▲ 2% vs 2022 (€ 3,263,626) Favourable step	€ 15,935,721 Equity 2024: € 15,935,721 ▲ € 12.6 million vs 2023 (€ 3,340,662) Favourable step	€ 15,869,558 Equity 2025: € 15,869,558 Unchanged (€ 15,935,721) Unfavourable step
Total debts	€ 16,124,708 Total debts 2022: € 16,124,708 First fiscal year in the series	€ 17,284,852 Total debts 2023: € 17,284,852 ▲ 7% vs 2022 (€ 16,124,708) Unfavourable step	€ 2,305,769 Total debts 2024: € 2,305,769 ▼ 87% vs 2023 (€ 17,284,852) Favourable step	€ 2,899,241 Total debts 2025: € 2,899,241 ▲ 26% vs 2024 (€ 2,305,769) Unfavourable step	▲ 26%
Cash	€ 731,139 Cash 2022: € 731,139 First fiscal year in the series	€ 259,325 Cash 2023: € 259,325 ▼ 65% vs 2022 (€ 731,139) Unfavourable step	€ 1,059,504 Cash 2024: € 1,059,504 ▲ € 800,179 vs 2023 (€ 259,325) Favourable step	€ 1,365,050 Cash 2025: € 1,365,050 ▲ 29% vs 2024 (€ 1,059,504) Favourable step	▲ 29%
Retained profit	€ 2,346,420 Retained profit 2022: € 2,346,420 First fiscal year in the series	€ 2,423,456 Retained profit 2023: € 2,423,456 ▲ 3% vs 2022 (€ 2,346,420) Favourable step	€ 1,018,515 Retained profit 2024: € 1,018,515 ▼ 58% vs 2023 (€ 2,423,456) Unfavourable step	€ 952,351 Retained profit 2025: € 952,351 ▼ 6% vs 2024 (€ 1,018,515) Unfavourable step	▼ 6%
Balance sheet total	€ 19,388,334 Balance sheet total 2022: € 19,388,334 First fiscal year in the series	€ 20,625,514 Balance sheet total 2023: € 20,625,514 ▲ 6% vs 2022 (€ 19,388,334) Unchanged	€ 18,241,489 Balance sheet total 2024: € 18,241,489 ▼ 12% vs 2023 (€ 20,625,514) Unchanged	€ 18,768,799 Balance sheet total 2025: € 18,768,799 ▲ 3% vs 2024 (€ 18,241,489) Unchanged	▲ 3%
Employees (FTE)	10.8 Employees (FTE) 2022: 10.8 First fiscal year in the series	11.1 Employees (FTE) 2023: 11.1 ▲ 0.3 vs 2022 (10.8) Unchanged	11.8 Employees (FTE) 2024: 11.8 ▲ 0.7 vs 2023 (11.1) Unchanged	10.8 Employees (FTE) 2025: 10.8 ▼ 1 vs 2024 (11.8) Unchanged	▼ 1

Key figures of BELRO MEDICAL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to BELRO MEDICAL?

What happened at BELRO MEDICAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2031 Alexandra. VEITHEN. stepped down as director. NBB
2031 Noleen Shiela MC CLOSKEY stepped down as director. NBB
Jun 8, 2026 New annual accounts for financial year 2025: loss of € 66,163. Source: NBB ↗
2025 Alexandra. VEITHEN. became a director. NBB
2025 Noleen Shiela MC CLOSKEY became a director. NBB
2025 PHILIPPE MARCHAND stepped down as director. NBB
2025 Alexandra VEITHEN stepped down as director. NBB
2024 PHILIPPE MARCHAND became a director. NBB

In short

From € 77,174 profit in 2022 to € 66,163 loss in 2025.

Paid € 57,095 in corporate taxes since 2022.

Best year ever: 2022, with € 77,174 profit.

On average € 315,100 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Directors

According to the 2025 annual accounts

Alexandra. VEITHEN.

Managing director

since 2025 · until 2031

Noleen Shiela MC CLOSKEY

Managing director

since 2025 · until 2031

Alexandra VEITHEN

Director

since 2020 · until 2025

PHILIPPE MARCHAND

Managing director

since 2024 · until 2025

Establishments

Establishment units

Physical locations of this company

Registered office

Drève Richelle 161 box 28

1410 Waterloo

2.068.363.167

Drève Richelle 161

1410 Waterloo

Active since 18 February 2000

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 10 companies are registered at this address.

All companies at this address →

BELAIRBUS

B- FINANCES

€ -13,888 gross margin · 2025

BATIMELEC

€ 15,076 gross margin · 2024

INTERNATIONAL MONTAGE MAINTENANCE

€ 11.5 million revenue · 2025

H.A.B.S.

€ -18,903 gross margin · 2026

+5 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0453.278.228

VAT number

BE 0453.278.228

Registered office

Drève Richelle 161 bus 28, 1410 Waterloo

Names & denominations

BELRO MEDICAL

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

16 August 1994

Peppol

Active · Active since 24 Sept 2025

Activities · NACE

Activiteiten van holdings

Managementactiviteiten van holdings

Medische praktijken

Activiteiten van medisch specialisten

Holdings

View on CBE Public ↗ Annual accounts (NBB) ↗

BELRO MEDICAL

Warning lights

Financials

What happened to BELRO MEDICAL?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions